Merck

Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
Merck still in the market for deals in the $1B to $15B range, CEO says
Fierce Pharma
Thu, 02/1/24 - 10:56 pm
Merck
M&A
Pharma CEOs
Rob Davis
Prometheus Biosciences
Merck seeks more deals to prepare for Keytruda's revenue decline
Yahoo/Reuters
Thu, 02/1/24 - 11:24 am
Merck
earnings
Keytruda
Merck inks research deal with Culmination Bio to leverage ‘powerful’ patient data platform
Biopharma Reporter
Tue, 01/30/24 - 10:32 am
Merck
Culmination Bio
Intermountain Health
R&D
J&J, Merck CEOs to testify at Senate panel after Sanders’ subpoena threats
Medical Marketing and Media
Mon, 01/29/24 - 10:32 pm
JNJ
Merck
Pharma CEOs
Joaquin Duato
Robert Davis
Senate
drug pricing
Bernie Sanders
After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer
Fierce Pharma
Fri, 01/26/24 - 12:03 pm
Merck
Keytruda
bladder cancer
Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says
Stat
Thu, 01/25/24 - 09:14 pm
drug pricing
Bernie Sanders
Pharma CEOs
Merck
Robert Davis
Merck finds drug discovery DALL-E, becoming early user of small molecule generative AI tool
Fierce Biotech
Thu, 01/25/24 - 10:49 am
Merck
drug discovery
artificial intelligence
generative AI
Variational AI
small molecule drugs
Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’
Fierce Biotech
Tue, 01/23/24 - 11:00 am
Merck
macrocycle drugs
drug discovery
Unnatural Products
Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
Stat
Thu, 01/18/24 - 04:58 pm
Bernie Sanders
drug pricing
Pharma CEOs
JNJ
Merck
Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use
Yahoo/Zacks.com
Tue, 01/16/24 - 09:46 am
Merck
cervical cancer
Keytruda
FDA
7 JPM Announcements You Don’t Want to Miss
MedCity News
Fri, 01/12/24 - 09:51 am
JPMHC 2024
Boston Scientfic
M&A
Axonics
Amazon
JNJ
Mayo Clinic
artificial intelligence
diabetes
Abbott Labs
Innovaccer
Merck
JPM24: Merck expects $20B+ in new cancer sales thanks to Daiichi ADC deal, Moderna vaccine
Fierce Pharma
Tue, 01/9/24 - 10:44 am
Merck
JPMHC 2024
Pharma CEOs
Robert Davis
Merck inks $680M Harpoon buyout, spearing challenger to Amgen T-cell engager
Fierce Biotech
Mon, 01/8/24 - 11:36 am
Merck
Harpoon Therapeutics
M&A
T-cell engager
JPMHC 2024
Merck seeks GLP-1 drugs with benefits beyond weight loss - CEO
Reuters
Fri, 01/5/24 - 11:28 am
Merck
Pharma CEOs
Rob Davis
GLP-1 agonist
Merck settles with insurance companies over $1.4B claim tied to 2017 cyberattack: report
Fierce Pharma
Fri, 01/5/24 - 10:08 am
Merck
legal
cybersecurity
cyberattacks
FDA ends busy year with three drug rejections
BioPharma Dive
Tue, 01/2/24 - 10:13 pm
FDA
Amgen
Zealand Pharma
Merck
Merck’s Chronic Cough Drug Fails to Secure FDA Approval for Second Time
BioSpace
Thu, 12/21/23 - 11:36 am
Merck
gefapixant
chronic cough
FDA
FDA accepts Merck’s pneumococcal vaccine BLA for priority review
Pharmaceutical Technology
Wed, 12/20/23 - 09:34 am
Merck
vaccines
FDA
pneumococcal disease
V116
Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer
Fierce Pharma
Tue, 12/19/23 - 10:26 am
Merck
Astellas
Pfizer
Keytruda
Padcev
bladder cancer

Pages